sevoflurane and remifentanil is one of 42 small molecule programs targeting Hypotension. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
54 competitors in Hypotension
Neo-Synephrine
Zofran
Ephedrine Sulfate
Proamatine
Intropin
Florinef
Dobutrex
Robinul
Cardene
Precedex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details